Bearish flow noted in Aurinia Pharmaceuticals with 4,024 puts trading, or 7x expected. Most active are Dec-23 8 puts and Dec-23 8 calls, with total volume in those strikes near 4,300 contracts. The Put/Call Ratio is 2.62, while ATM IV is up nearly 8 points on the day. Earnings are expected on February 27th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AUPH:
- Aurinia Pharmaceuticals call volume above normal and directionally bullish
- Aurinia strength may be related to Gilead suspicion, says Gordon Haskett
- Aurinia Pharmaceuticals partner Otsuka files NDA in Japan for Lupkynis
- Aurinia Pharmaceuticals narrows FY23 net product revenue to $155M-$160M
- Aurinia Pharmaceuticals reports Q3 EPS (9c), consensus (17c)